The Digital Source For China's Tech Innovation Since 2000

China Tech Buzz

Global News Impacting Chinese Tech

DeepSeek jolts AI industry: Why AI's next leap may not come from more data, but more compute at inference

April 6, 2025
Source: venturebeat.com venturebeat.com
News Snapshot:
Join our daily and weekly newsletters for the latest updates and exclusive content on industry-leading AI coverage. Learn More The AI landscape continues to evolve at a rapid pace, with recent developments challenging established paradigms. Early in 2025, Chinese AI lab DeepSeek unveiled a new model that sent shockwaves through the AI industry and resulted in a 17% drop in Nvidia’s stock, along with other stocks related to AI data center demand. This market reaction was widely reported to stem from DeepSeek’s apparent ability to deliver high-performance models at a fraction of the cost of rivals in the U.S., sparking...
GO TO ORIGINAL SOURCE →
China Tech Buzz Topics: AI | AI Labs | API | applications | AWS | Azure | block | Business | Canada | chatbot | China | Chinese | chip | chips | cloud | consumer | content | data | data center | development | education | enterprise | fine | GPU | hardware

Other News:

Investigation Launched into DoorDash's Use of Moonshot AI's Kimi K2.6 Model

August 1, 2026

Brookfield, Cameco plan IPO of jointly owned nuclear power company Westinghouse

August 1, 2026
theglobeandmail.com theglobeandmail.com

Trump AI executive order nears key deadline regulation debate heats up

August 1, 2026
cnbc.com cnbc.com

The FCC Just Banned Most Robot Vacuums. Here's What That Means

August 1, 2026
cnet.com cnet.com

Twitch Streamer Ludwig Appears As An NPC In A Chinese FMV Game

August 1, 2026
kotaku.com kotaku.com

Why Australia ships out its wealth – and buys it back as finished goods

August 1, 2026
sbs.com.au sbs.com.au

Palantir CTO says the power grid is a bigger AI threat than China

August 1, 2026
foxnews.com foxnews.com

FDA approves Pluvicto for PSMA+ metastatic hormone-sensitive prostate cancer (mHSPC), advancing potential new standard of care across metastatic disease

August 1, 2026
manilatimes.net manilatimes.net

FDA approves Pluvicto for PSMA+ metastatic

August 1, 2026
globenewswire.com globenewswire.com
  • Contact Us
  • About Us
  • Corrections and Disclosure
  • Privacy Policy
  • Terms & Conditions
  • Contact Us
  • About Us
  • Corrections and Disclosure
  • Privacy Policy
  • Terms & Conditions
© 2026 ChinaTechNews.com. A Service of Asia Media Network.